These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1006 related items for PubMed ID: 12414664
21. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. Erickson BA, Longo WE, Panesar N, Mazuski JE, Kaminski DL. J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067 [Abstract] [Full Text] [Related]
22. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K. Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902 [Abstract] [Full Text] [Related]
23. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Li M, Wu X, Xu XC. Clin Cancer Res; 2001 Apr; 7(4):1010-6. PubMed ID: 11309352 [Abstract] [Full Text] [Related]
24. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ. Cancer Res; 1997 Jun 15; 57(12):2452-9. PubMed ID: 9192825 [Abstract] [Full Text] [Related]
25. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo. Johnsen JI, Lindskog M, Ponthan F, Pettersen I, Elfman L, Orrego A, Sveinbjörnsson B, Kogner P. Cancer Res; 2004 Oct 15; 64(20):7210-5. PubMed ID: 15492235 [Abstract] [Full Text] [Related]
26. Celecoxib activates a novel mitochondrial apoptosis signaling pathway. Jendrossek V, Handrick R, Belka C. FASEB J; 2003 Aug 15; 17(11):1547-9. PubMed ID: 12824303 [Abstract] [Full Text] [Related]
27. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor. Hu KQ, Yu CH, Mineyama Y, McCracken JD, Hillebrand DJ, Hasan M. Int J Oncol; 2003 Apr 15; 22(4):757-63. PubMed ID: 12632065 [Abstract] [Full Text] [Related]
28. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Cancer Res; 1998 Jan 15; 58(2):362-6. PubMed ID: 9443418 [Abstract] [Full Text] [Related]
29. Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents. Rodríguez-Burford C, Barnes MN, Oelschlager DK, Myers RB, Talley LI, Partridge EE, Grizzle WE. Clin Cancer Res; 2002 Jan 15; 8(1):202-9. PubMed ID: 11801560 [Abstract] [Full Text] [Related]
30. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA. Cancer Res; 1999 Sep 01; 59(17):4356-62. PubMed ID: 10485483 [Abstract] [Full Text] [Related]
31. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells. Bottone FG, Martinez JM, Alston-Mills B, Eling TE. Carcinogenesis; 2004 Mar 01; 25(3):349-57. PubMed ID: 14633654 [Abstract] [Full Text] [Related]
32. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Yu HP, Shi LY, Lu WH, Su YH, Li YY, Xu SQ. J Gastroenterol Hepatol; 2004 Jun 01; 19(6):638-42. PubMed ID: 15151617 [Abstract] [Full Text] [Related]
33. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Liu X, Yue P, Zhou Z, Khuri FR, Sun SY. J Natl Cancer Inst; 2004 Dec 01; 96(23):1769-80. PubMed ID: 15572759 [Abstract] [Full Text] [Related]
34. Expression of cyclooxygenase 2 in human malignant melanoma. Denkert C, Köbel M, Berger S, Siegert A, Leclere A, Trefzer U, Hauptmann S. Cancer Res; 2001 Jan 01; 61(1):303-8. PubMed ID: 11196178 [Abstract] [Full Text] [Related]
35. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G. FASEB J; 2001 Dec 01; 15(14):2742-4. PubMed ID: 11606477 [Abstract] [Full Text] [Related]
36. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells. Pelzmann M, Thurnher D, Gedlicka C, Martinek H, Knerer B. J Oral Pathol Med; 2004 Nov 01; 33(10):607-13. PubMed ID: 15482327 [Abstract] [Full Text] [Related]
37. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model. Nishikawa M, Stapleton PP, Freeman TA, Gaughan JP, Matsuda T, Daly JM. J Am Coll Surg; 2004 Sep 01; 199(3):428-35. PubMed ID: 15325613 [Abstract] [Full Text] [Related]
38. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells. Liu CY, Lai YY, Lo CJ. J Surg Res; 2004 Apr 01; 117(2):223-31. PubMed ID: 15047127 [Abstract] [Full Text] [Related]
39. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase. Réti A, Pap E, Adleff V, Jeney A, Kralovánszky J, Budai B. Cancer Chemother Pharmacol; 2010 Jul 01; 66(2):219-27. PubMed ID: 19830428 [Abstract] [Full Text] [Related]
40. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells. Cheng AS, Chan HL, Leung WK, Wong N, Johnson PJ, Sung JJ. Int J Oncol; 2003 Jul 01; 23(1):113-9. PubMed ID: 12792783 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]